Rise in prevalence of breast cancer is augmenting the breast biopsy devices market size. Breast cancer is the most commonly diagnosed type of cancer in women. A breast biopsy is the only diagnostic tool that can definitively determine the presence of cancer.
Surge in investment in Artificial Intelligence (AI) diagnostics is also boosting the breast biopsy devices market demand. AI has the potential to improve breast cancer screening. It can offer accuracy that surpasses traditional DNA-based approaches.
Manufacturers of breast biopsy devices are offering image-guided breast biopsy solutions. These solutions can evaluate microcalcifications seen on the mammogram and cystic or solid mass seen on the mammogram or ultrasound.
Breast biopsy is a test that removes cells or tissue from the breast for diagnosis. It offers important information about breast tissues, which helps in effective diagnosis and disease management.
A biopsy is the only test that can diagnose or confirm breast cancer. Needle biopsy and surgical biopsy are the two main types of biopsies. In some cases, a biopsy may be used to completely remove small breast abnormalities.
A needle biopsy is a quick and effective test for finding out about the nature of uncertain tissue. A needle biopsy uses a hollow needle to remove samples of tissue or cells from the breast. Core needle biopsy is the standard way to diagnose breast cancer.
However, some people need a surgical biopsy to get complete information about the tumor. Most surgical biopsies are excisional biopsies. Fine needle aspiration (also known as FNA or fine needle biopsy) is only used for lumps that can be felt. FNA is sometimes done as a quick way to sample a breast lump.
Recent market trends indicate the development of advanced breast biopsy devices for accurate diagnosis. The Advanced Breast Biopsy Instrumentation (ABBI) System is a device for diagnostic biopsy of detected breast lesions. The procedure involves the utilization of a stereotactic imaging system.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Breast cancer is the most common cancer in women. The disease is prevalent in every country in the world. In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally, according to the World Health Organization (WHO). Thus, high prevalence of breast cancer is fueling the breast biopsy devices market dynamics.
New disposable breast tissue sampling devices are gaining traction in the market. In May 2024, Hologic launched its Brevera breast biopsy system 7-gauge needle in Europe.
The new disposable 7-gauge needle can be used on the system’s existing reusable device driver, which allows the Brevera system to support new functionality, simplify storage, and reduce waste. Thus, availability of disposable breast tissue sampling devices is expected to spur the breast biopsy devices market growth in the near future.
Artificial intelligence(AI) can be trained to recognize patterns in large amounts of data. It can evaluate new data on its own and start making predictions. In September 2023, Ibex raised US$ 55 Mn to expand the reach of its AI-powered cancer diagnostics.
Ibex’s Galen platform utilizes deep learning AI algorithms to analyze pathology slides for signs of cancer. This is expected to help pathologists increase their diagnostic accuracy and make their workflows more efficient. Hence, rise in investment in AI diagnostics is propelling the breast biopsy devices market revenue.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest breast biopsy devices market analysis, North America held largest share in 2023. High prevalence of breast cancer is augmenting the market statistics in the region.
According to the American Cancer Society, about 310,720 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in 2024. Moreover, about 42,250 women are likely to die from breast cancer in the country.
Surge in risk of breast cancer is driving the breast biopsy devices market share in Asia Pacific. In 2023, the ‘Impact and Opportunity: The Case for Investing in Women’s Cancers in Asia Pacific’ report, stated that the female population in Asia Pacific is at a disproportionately higher risk of developing breast and cervical cancers when compared to those worldwide.
Key players operating in the global breast biopsy devices market are focused on the R&D of robotic biopsy systems. They are also integrating Magnetic Resonance Imaging (MRI), AI, and robotics to improve diagnostic capabilities.
In 2023, Insight Medbotics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IGAR system, a magnetic resonance imaging (MRI)-compatible robot used for breast biopsy indications.
Hologic, Inc., Becton, Dickinson and Company (BD), Medtronic, Danaher Corporation, Siemens Healthineers AG, Mammotome (Devicor Medical Products, Inc.), Carestream Health, AURORA HEALTHCARE US CORP., and Stryker are key companies in the breast biopsy devices industry.
These companies have been profiled in the breast biopsy devices market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 2.1 Bn |
| Market Forecast (Value) in 2034 | US$ 3.9 Bn |
| Growth Rate (CAGR) | 5.7% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 2.1 Bn in 2023
It is projected to grow at a CAGR of 5.7% from 2024 to 2034
Rise in prevalence of breast cancer and surge in investment in artificial intelligence diagnostics
North America was the dominant region in 2023
Hologic, Inc., Becton, Dickinson and Company (BD), Medtronic, Danaher Corporation, Siemens Healthineers AG, Mammotome (Devicor Medical Products, Inc.), Carestream Health, AURORA HEALTHCARE US CORP., and Stryker
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Biopsy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Biopsy Devices Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Breast Biopsy Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Core Needle Biopsy Devices
6.3.2. Vacuum-assisted Biopsy Devices
6.3.3. Fine Needle Aspiration Biopsy Devices
6.3.4. Surgical Biopsy Devices
6.3.5. Others
6.4. Market Attractiveness, by Product Type
7. Global Breast Biopsy Devices Market Analysis and Forecast, by Guidance Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Guidance Technique, 2020-2034
7.3.1. Ultrasound-guided Biopsy
7.3.2. MRI-guided Biopsy
7.3.3. Mammography-guided Biopsy
7.3.4. Stereotactic-guided Biopsy
7.4. Market Attractiveness, by Guidance Technique
8. Global Breast Biopsy Devices Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Screening
8.3.2. Diagnostic
8.3.3. Surveillance
8.4. Market Attractiveness, by Application
9. Global Breast Biopsy Devices Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Diagnostic Imaging Centers
9.3.4. Ambulatory Surgical Centers
9.4. Market Attractiveness, by End-user
10. Global Breast Biopsy Devices Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Breast Biopsy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Core Needle Biopsy Devices
11.2.2. Vacuum-assisted Biopsy Devices
11.2.3. Fine Needle Aspiration Biopsy Devices
11.2.4. Surgical Biopsy Devices
11.2.5. Others
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Guidance Technique, 2020-2034
11.4.1. Ultrasound-guided Biopsy
11.4.2. MRI-guided Biopsy
11.4.3. Mammography-guided Biopsy
11.4.4. Stereotactic-guided Biopsy
11.5. Market Attractiveness, by Guidance Technique
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Screening
11.6.2. Diagnostic
11.6.3. Surveillance
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Specialty Clinics
11.8.3. Diagnostic Imaging Centers
11.8.4. Ambulatory Surgical Centers
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Guidance Technique
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Breast Biopsy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Core Needle Biopsy Devices
12.2.2. Vacuum-assisted Biopsy Devices
12.2.3. Fine Needle Aspiration Biopsy Devices
12.2.4. Surgical Biopsy Devices
12.2.5. Others
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Guidance Technique, 2020-2034
12.4.1. Ultrasound-guided Biopsy
12.4.2. MRI-guided Biopsy
12.4.3. Mammography-guided Biopsy
12.4.4. Stereotactic-guided Biopsy
12.5. Market Attractiveness, by Guidance Technique
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Screening
12.6.2. Diagnostic
12.6.3. Surveillance
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Specialty Clinics
12.8.3. Diagnostic Imaging Centers
12.8.4. Ambulatory Surgical Centers
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Guidance Technique
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Breast Biopsy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Core Needle Biopsy Devices
13.2.2. Vacuum-assisted Biopsy Devices
13.2.3. Fine Needle Aspiration Biopsy Devices
13.2.4. Surgical Biopsy Devices
13.2.5. Others
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Guidance Technique, 2020-2034
13.4.1. Ultrasound-guided Biopsy
13.4.2. MRI-guided Biopsy
13.4.3. Mammography-guided Biopsy
13.4.4. Stereotactic-guided Biopsy
13.5. Market Attractiveness, by Guidance Technique
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Screening
13.6.2. Diagnostic
13.6.3. Surveillance
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Specialty Clinics
13.8.3. Diagnostic Imaging Centers
13.8.4. Ambulatory Surgical Centers
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Guidance Technique
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Breast Biopsy Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Core Needle Biopsy Devices
14.2.2. Vacuum-assisted Biopsy Devices
14.2.3. Fine Needle Aspiration Biopsy Devices
14.2.4. Surgical Biopsy Devices
14.2.5. Others
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Guidance Technique, 2020-2034
14.4.1. Ultrasound-guided Biopsy
14.4.2. MRI-guided Biopsy
14.4.3. Mammography-guided Biopsy
14.4.4. Stereotactic-guided Biopsy
14.5. Market Attractiveness, by Guidance Technique
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Screening
14.6.2. Diagnostic
14.6.3. Surveillance
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Specialty Clinics
14.8.3. Diagnostic Imaging Centers
14.8.4. Ambulatory Surgical Centers
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Guidance Technique
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Breast Biopsy Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Core Needle Biopsy Devices
15.2.2. Vacuum-assisted Biopsy Devices
15.2.3. Fine Needle Aspiration Biopsy Devices
15.2.4. Surgical Biopsy Devices
15.2.5. Others
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Guidance Technique, 2020-2034
15.4.1. Ultrasound-guided Biopsy
15.4.2. MRI-guided Biopsy
15.4.3. Mammography-guided Biopsy
15.4.4. Stereotactic-guided Biopsy
15.5. Market Attractiveness, by Guidance Technique
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Screening
15.6.2. Diagnostic
15.6.3. Surveillance
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Specialty Clinics
15.8.3. Diagnostic Imaging Centers
15.8.4. Ambulatory Surgical Centers
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Guidance Technique
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Hologic, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Becton, Dickinson and Company (BD)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Medtronic
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Danaher Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Siemens Healthineers AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Mammotome (Devicor Medical Products, Inc.)
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Carestream Health
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. AURORA HEALTHCARE US CORP.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Stryker
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
List of Tables
Table 01: Global Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 02: Global Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Guidance Technique, 2020-2034
Table 03: Global Breast Biopsy Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 05: Global Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 06: North America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 07: North America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 08: North America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Guidance Technique, 2020-2034
Table 09: North America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 10: North America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 11: Europe Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 13: Europe Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Guidance Technique, 2020-2034
Table 14: Europe Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 15: Europe Breast Biopsy Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 16: Asia Pacific Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 18: Asia Pacific Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Guidance Technique, 2020-2034
Table 19: Asia Pacific Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Asia Pacific Breast Biopsy Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Latin America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 23: Latin America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Guidance Technique, 2020-2034
Table 24: Latin America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 25: Latin America Breast Biopsy Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 26: Middle East & Africa Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 28: Middle East & Africa Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Guidance Technique, 2020-2034
Table 29: Middle East & Africa Breast Biopsy Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 30: Middle East & Africa Breast Biopsy Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Breast Biopsy Devices Market Size (US$ Mn), by Region, 2023 and 2034
Figure 02: Global Breast Biopsy Devices Market Revenue (US$ Mn), by Product Type, 2023
Figure 03: Global Breast Biopsy Devices Market Value Share, by Product Type, 2023
Figure 04: Global Breast Biopsy Devices Market Revenue (US$ Mn), by Guidance Technique, 2023
Figure 05: Global Breast Biopsy Devices Market Value Share, by Guidance Technique, 2023
Figure 06: Global Breast Biopsy Devices Market Revenue (US$ Mn), by Application, 2023
Figure 07: Global Breast Biopsy Devices Market Value Share, by Application, 2023
Figure 08: Global Breast Biopsy Devices Market Revenue (US$ Mn), by End-user, 2023
Figure 09: Global Breast Biopsy Devices Market Value Share, by End-user, 2023
Figure 10: Global Breast Biopsy Devices Market Value Share, by Region, 2023
Figure 11: Global Breast Biopsy Devices Market Value (US$ Mn) Forecast, 2020-2034
Figure 12: Global Breast Biopsy Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 13: Global Breast Biopsy Devices Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 14: Global Breast Biopsy Devices Market Value Share Analysis, by Guidance Technique, 2023 and 2034
Figure 15: Global Breast Biopsy Devices Market Attractiveness Analysis, by Guidance Technique, 2024-2034
Figure 16: Global Breast Biopsy Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 17: Global Breast Biopsy Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 18: Global Breast Biopsy Devices Market Revenue (US$ Mn), by End-user, 2023
Figure 19: Global Breast Biopsy Devices Market Value Share, by End-user, 2023
Figure 20: Global Breast Biopsy Devices Market Value Share Analysis, by Region, 2023 and 2034
Figure 21: Global Breast Biopsy Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 22: North America Breast Biopsy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 23: North America Breast Biopsy Devices Market Attractiveness Analysis, by Country, 2024-2034
Figure 24: North America Breast Biopsy Devices Market Value Share Analysis, by Country, 2023 and 2034
Figure 25: North America Breast Biopsy Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 26: North America Breast Biopsy Devices Market Value Share Analysis, by Guidance Technique, 2023 and 2034
Figure 27: North America Breast Biopsy Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 28: North America Breast Biopsy Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 29: North America Breast Biopsy Devices Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 30: North America Breast Biopsy Devices Market Attractiveness Analysis, by Guidance Technique, 2024-2034
Figure 31: North America Breast Biopsy Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 32: North America Breast Biopsy Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 33: Europe Breast Biopsy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 34: Europe Breast Biopsy Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 35: Europe Breast Biopsy Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 36: Europe Breast Biopsy Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 37: Europe Breast Biopsy Devices Market Value Share Analysis, by Guidance Technique, 2023 and 2034
Figure 38: Europe Breast Biopsy Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 39: Europe Breast Biopsy Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Europe Breast Biopsy Devices Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 41: Europe Breast Biopsy Devices Market Attractiveness Analysis, by Guidance Technique, 2024-2034
Figure 42: Europe Breast Biopsy Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 43: Europe Breast Biopsy Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 44: Asia Pacific Breast Biopsy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 45: Asia Pacific Breast Biopsy Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 46: Asia Pacific Breast Biopsy Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 47: Asia Pacific Breast Biopsy Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 48: Asia Pacific Breast Biopsy Devices Market Value Share Analysis, by Guidance Technique, 2023 and 2034
Figure 49: Asia Pacific Breast Biopsy Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Asia Pacific Breast Biopsy Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Asia Pacific Breast Biopsy Devices Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 52: Asia Pacific Breast Biopsy Devices Market Attractiveness Analysis, by Guidance Technique, 2024-2034
Figure 53: Asia Pacific Breast Biopsy Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 54: Asia Pacific Breast Biopsy Devices Market Attractiveness Analysis, by End-user, 2023-2034
Figure 55: Latin America Breast Biopsy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 56: Latin America Breast Biopsy Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 57: Latin America Breast Biopsy Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 58: Latin America Breast Biopsy Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 59: Latin America Breast Biopsy Devices Market Value Share Analysis, by Guidance Technique, 2023 and 2034
Figure 60: Latin America Breast Biopsy Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 61: Latin America Breast Biopsy Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 62: Latin America Breast Biopsy Devices Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 63: Latin America Breast Biopsy Devices Market Attractiveness Analysis, by Guidance Technique, 2024-2034
Figure 64: Latin America Breast Biopsy Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 65: Latin America Breast Biopsy Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 66: Middle East & Africa Breast Biopsy Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 67: Middle East & Africa Breast Biopsy Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 68: Middle East & Africa Breast Biopsy Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 69: Middle East & Africa Breast Biopsy Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 70: Middle East & Africa Breast Biopsy Devices Market Value Share Analysis, by Guidance Technique, 2023 and 2034
Figure 71: Middle East & Africa Breast Biopsy Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 72: Middle East & Africa Breast Biopsy Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 73: Middle East & Africa Breast Biopsy Devices Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 74: Middle East & Africa Breast Biopsy Devices Market Attractiveness Analysis, by Guidance Technique, 2024-2034
Figure 75: Middle East & Africa Breast Biopsy Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 76: Middle East & Africa Breast Biopsy Devices Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Breast Biopsy Devices Market
